Peptide Initiative

Peptide profile · Healing & Recovery

Apelin-13

A natural heart hormone that helps your cardiovascular system work better and supports healthy blood flow throughout your body.

Moderate human trialsResearch compound
Minutes in plasma; varies by route of administrationHalf-life
~90-95%Bioavailability (subcutaneous injection)
1550.8Molecular weight, Da

Molecular formula

C69H111N23O16S

CAS number
Not yet assigned (research compound)
PubChem
25078060
Developed · 1998
Research Team, Academic Research Institutions

Amino acid sequence

QRPRLSHKGPMPF (13 amino acids)

Cardiovascular SupportHelps maintain normal blood pressure and cardiovascular function

8.2

Heart Function & StrengthSupports healthy heart muscle contraction and strength

7.8

Blood Flow & CirculationPromotes healthy blood vessel formation and blood flow

7.4

Ratings out of 10.

30 nmol/min

Every documented dose level

PhaseDoseFrequency
5 minutes per dose step (research setting)30 nmol/minContinuous infusion
5 minutes per dose step (research setting)100 nmol/minContinuous infusion
5 minutes per dose step (research setting)300 nmol/minContinuous infusion
Build my protocolBuild my protocol opens your schedule and dose log to save, share and keep on your phone.

Best for research into cardiovascular health and heart function & understanding how the body naturally protects the heart

Best for

  • Research into cardiovascular health and heart function

    Apelin-13 is particularly well-suited for individuals focused on research into cardiovascular health and heart function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach .

  • Understanding how the body naturally protects the heart

    Apelin-13 is particularly well-suited for individuals focused on understanding how the body naturally protects the heart. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach .

  • Exploring potential treatments for heart failure

    Apelin-13 is particularly well-suited for individuals focused on exploring potential treatments for heart failure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach .

  • Studying mechanisms of heart muscle strength

    Apelin-13 is particularly well-suited for individuals focused on studying mechanisms of heart muscle strength. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach .

Consider alternatives if

Alternative approaches for healing & recovery supportConsult your healthcare provider for alternatives to Apelin-13 based on your specific needs and medical history
Alternative healing peptidesBPC-157TB-500 (Thymosin Beta-4)GHK-Cu
Non-peptide recovery optionsPlatelet-Rich Plasma (PRP)Collagen supplementsPhysical therapy

Do not use if

  • Currently under investigation - not for human clinical use
  • May interact with blood pressure medications (in theory)
  • Should not be used if allergic to peptides or component amino acids
  • Pregnant or breastfeeding individuals should avoid

Use with caution if

  • You are taking other medications—discuss potential interactions with your healthcare provider
  • You have a history of liver or kidney disease
  • You are elderly or have multiple medical conditions
  • You are planning surgery in the near future—inform your surgeon about Apelin-13 use
  • You have any chronic health conditions that require regular monitoring

Not sure?

Compare Apelin-13 with similar peptides to find the best fit for your goals.

Route

Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Best sites

  • Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
  • Front of thighs—middle to upper portion of the outer leg
  • Back of upper arm—outer area (may need assistance from another person)

The Apelin-13 dosing protocol covers how it is taken.

9 common side effects · serious: no data

Emergency signs first, then what this page and MedlinePlus say.

Apelin-13 is a research compound with no human clinical trials or FDA approval.

All safety data comes from animal studies and in vitro mechanistic work showing beneficial effects on vascular function and cardiac remodeling. However, animal models do not predict human safety, and the peptide's effects on immune regulation in humans remain untested.

No dose-ranging studies, pharmacokinetics, or organ accumulation data exist in humans. The APJ receptor is expressed in multiple tissues including brain, raising concerns about off-target neurological effects at high doses.

Evidence consists entirely of animal studies in mice, rats, and larger mammals, plus in vitro receptor binding and vascular biology research. No human pharmacokinetics, toxicology screening, Phase 1 safety studies, or clinical efficacy trials have been conducted.

The literature base is mechanistic rather than empirical safety data.


Common side effects · experienced by some users

Mild changes in blood pressure

Mild changes in blood pressure

Management
Consult your healthcare provider for guidance.

Minimal systemic effects in animal studies

Minimal systemic effects in animal studies

Management
Consult your healthcare provider for guidance.

Headache (theoretical, based on blood pressure effects)

Headache (theoretical, based on blood pressure effects)

Management
Consult your healthcare provider for guidance.

Flushing or warmth at injection site

Flushing or warmth at injection site

Management
Consult your healthcare provider for guidance.

Mild inflammation at injection site

Mild inflammation at injection site

Management
Consult your healthcare provider for guidance.

Dizziness if blood pressure drops too quickly

Dizziness if blood pressure drops too quickly

Management
Consult your healthcare provider for guidance.

Allergic reactions to the peptide

Allergic reactions to the peptide

Management
Consult your healthcare provider for guidance.

Heart rhythm changes (requires monitoring)

Heart rhythm changes (requires monitoring)

Management
Consult your healthcare provider for guidance.

Blood pressure, heart rate, cardiac function

Blood pressure, heart rate, cardiac function

Management
Consult your healthcare provider for guidance.

Serious side effects

Severe allergic reaction

In rare cases, Apelin-13 may trigger a severe allergic reaction including difficulty breathing, facial swelling, or widespread rash. This requires immediate medical attention.

Management
STOP treatment immediately and seek emergency medical care. Do not restart without medical clearance. Report all allergic reactions to your healthcare provider.


Stop and seek help if

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Apelin-13
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Apelin-13 should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.


With other peptides

  • SafeAPJ receptor agonist research compounds — May be used together under medical guidance.
  • SafeStudies on angiotensin II regulation (cardiovascular balance) — May be used together under medical guidance.
  • SafeMitochondrial health research (heart energy production) — May be used together under medical guidance.

With medications

  • CautionOther heart-active peptides without proper spacing and monitoring — Use with caution—discuss with your healthcare provider.
  • CautionACE inhibitors or ARBs (blood pressure medication - requires careful monitoring) — Use with caution—discuss with your healthcare provider.
  • CautionStimulant compounds that raise heart rate significantly — Use with caution—discuss with your healthcare provider.

With supplements

  • SafeMultivitamins — Generally safe to take alongside Apelin-13. Space doses apart if taking oral formulations to ensure optimal absorption.
  • SafeElectrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Moderate human trials · first signs minutes (immediate)

Evidence level

Moderate human trials

(Phase 1-2)

80/100

Regulatory status

Research compound

Onset of effects

Moderate

(1-2 weeks)


How it works

Apelin-13 is a peptide hormone that helps regulate blood pressure, heart function, and fluid balance.

It works through the APJ receptor to improve heart contractility and reduce fluid accumulation, making it potentially useful for heart failure .

The deeper mechanism

Apelin-13 is the 13-amino acid C-terminal fragment of apelin that activates the APJ receptor, a G-protein coupled receptor. APJ activation increases cardiac contractility, promotes vasodilation, and reduces vascular permeability.

In heart failure models, apelin signaling improves cardiac function and reduces hypertrophy.


What to expect

  1. Minutes (Immediate)

    What you might notice

    • Heart rate and blood pressure changes begin;
    • APJ receptor activation starts;
    • initial cardiac contractility increases

    What's normal

    • Initial response to Apelin-13 is beginning at the cellular level
    • Different individuals experience Apelin-13's onset at different rates
    • Transient systemic effects from initial Apelin-13 exposure are common

    What's next

    • Maintain consistent Apelin-13 administration as prescribed
    • Document subjective effects and physical markers daily
    • Schedule a check-in with your provider about initial observations
  2. Hours (Short-term)

    What you might notice

    • Peak effects on blood vessel relaxation;
    • improved blood flow throughout the body;
    • anti-inflammatory signaling begins

    What's normal

    • Apelin-13 is achieving sufficient receptor engagement
    • Initial mechanism of Apelin-13 is taking effect
    • Early transient effects from Apelin-13 administration are resolving

    What's next

    • Maintain consistent Apelin-13 administration as prescribed
    • Document subjective effects and physical markers daily
    • Schedule a check-in with your provider about initial observations
  3. Days to Weeks (Repeated Dosing)

    What you might notice

    • Adaptive cardiovascular responses;
    • improved heart muscle function with regular use;
    • potential protective effects building up

    What's normal

    • Apelin-13 response patterns are emerging
    • Initial Apelin-13 response is consistent with mechanism expectations
    • Early tolerance development to Apelin-13 is not expected

    What's next

    • Assess whether Apelin-13 response aligns with expectations
    • Plan next steps based on initial Apelin-13 tolerance and response
    • Establish baseline monitoring for Apelin-13 response tracking

Signs it's working

Treatment Response

  • Improvement in the primary symptoms or condition being treated
  • Positive changes in relevant lab values or clinical markers
  • Consistent, stable response to Apelin-13 over time
  • Reduction in symptom frequency or severity

Signs it's working

General Well-being

  • Improved energy levels and daily functioning
  • Better quality of life related to the treated condition
  • Manageable or absent side effects indicating good tolerance
  • Positive feedback from healthcare provider during check-ups

Not seeing results?

Common reasons

  • Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
  • Insufficient time at target dose—most compounds need several weeks to show full benefits
  • Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
  • Individual variation in response—genetics, metabolism, and other factors affect outcomes
  • Underlying conditions or medications interfering with absorption or effectiveness
  • Improper storage leading to degraded product—always verify proper storage conditions

What does Apelin-13 do in your body?

Apelin-13 is a natural hormone that makes your heart stronger and helps your blood flow better. It sends messages to your heart cells telling them to pump more efficiently and helps your blood vessels relax so blood can move through them more easily. It's like a natural boost for your cardiovascular system .

Is Apelin-13 approved by the FDA?

No, not yet. Apelin-13 is still in the research stage. Scientists are studying it in laboratories and on animals to understand how it works and how safe it is. It's not available as a medicine for people to use outside of approved clinical research studies .

How is Apelin-13 different from Apelin-36?

Apelin-13 and Apelin-36 are different lengths of the same peptide. Apelin-13 is shorter and often works faster and is easier for the body to use. Apelin-36 is longer and might stay active in your body longer. Both activate the APJ receptor, but scientists often prefer studying Apelin-13 because it's more manageable to work with .

What is the APJ receptor?

The APJ receptor is like a lock on your heart cells that apelin-13 is the key for. When apelin-13 binds to APJ receptors, it starts a chain of events inside the cell that improves heart function. This receptor was discovered in 1993, but scientists didn't find its natural key (apelin) until 1998 .

Could Apelin-13 help with heart disease?

That's the big question scientists are investigating right now. Early studies show promise that apelin-13 could help protect damaged hearts and improve heart function. However, much more research is needed before it can be used to treat people with heart disease. Several research teams are working on modified versions of apelin-13 that might be safer and more effective for patients .

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Apelin-13, on one page.

Apelin-13 dosing protocol

Medical disclaimer

Apelin-13 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 12, 2026

30 nmol/min Continuous infusion · onset 1-2 weeks
Open the Apelin-13 calculatorApelin-13 calculator